Bans not working at medical schools

Share this article:
Proper disclosure and good faith efforts are apparently not enough to enforce university bans on paid speaking programs.
Cross-referencing names on its new “Dollars for Docs” database with faculty at 12 medical schools and teaching hospitals, nonprofit independent newsroom ProPublica discovered that faculty at half also lectured for drug firms in the last two years, despite restrictions on such speeches.
Stanford, the University of Pennsylvania, the University of Pittsburgh and the University of Colorado Denver were among those that initiated internal reviews after being confronted with the findings. At Stanford, where more than a dozen doctors were paid speakers in apparent violation of its policy, Dean Dr. Philip Pizzo told PBS: “Across the board, everyone who's seen their names on this list has been very remorseful…and very quick to say that they were going to cease and desist this going forward…that's how change occurs.” The school, where a ban on sponsored talks dates to 2009, is evaluating what the consequences should be.
Wary of legal penalties for off-label discussions, drug firms, ProPublica noted separately, have become stricter in requiring paid speakers to stick to prepared slides. Critics of marketing question whether this smacks of plagiarism. Pizzo said collaboration with industry is important for innovations to move from bench to bedside. “What we don't want is our name and our reputation to serve as the marketing for industry.”
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?